IQLT - ETF AI Analysis
Top Page
iShares MSCI Intl Quality Factor ETF (IQLT)
Rating:69Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Quality-Focused Top Holdings
Several major holdings, including ASML, Shell, ABB, and Schneider Electric, have delivered strong performance, helping drive the fund’s returns.
Broad International Diversification
The fund spreads its investments across many countries such as the UK, Japan, Switzerland, the U.S., and others, which helps reduce reliance on any single market.
Negative Factors
Moderate Fee Level
The expense ratio is not especially low, so costs may be higher than some of the cheapest index ETFs available.
Concentration in a Few Large Positions
A small number of stocks, led by ASML with a relatively large weight, make up a meaningful share of the portfolio, increasing single-stock risk.
Mixed Performance Among Top Holdings
Some key positions like Roche, Nestlé, and Zurich Insurance have shown weak or negative performance, which can drag on overall returns if the trend continues.
IQLT vs. SPDR S&P 500 ETF (SPY)
AUM13.49B
RegionDeveloped Markets
Expense Ratio0.30%
Beta0.74
IssueriShares
Inception DateJan 13, 2015
Dividend Yield2.23%
Asset ClassEquity
Index TrackedWorld ex USA Sector Neutral Quality
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,147,535
30 Day Avg. Volume1,524,862
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
55.82Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering298
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
IQLT Summary
IQLT is the iShares MSCI Intl Quality Factor ETF, which follows the MSCI World ex USA Sector Neutral Quality index. It invests in “high quality” companies from developed countries outside the U.S., focusing on firms with strong finances and steady profits. The fund holds well-known names like ASML and Nestlé, and spreads investments across many countries and sectors, which can help with diversification and long-term growth potential. A key risk is that international stock prices can go up and down with global markets and currency movements, so your investment value may fluctuate.
How much will it cost me?The iShares MSCI Intl Quality Factor ETF (IQLT) has an expense ratio of 0.30%, which means you’ll pay $3 per year for every $1,000 invested. This is slightly higher than average for passively managed ETFs because it focuses on a specific strategy of selecting high-quality international stocks, which requires more specialized research and management.
What would affect this ETF?The iShares MSCI Intl Quality Factor ETF (IQLT) could benefit from continued global economic growth and increased demand for high-quality companies in developed markets outside the U.S., particularly in sectors like financials, technology, and healthcare. However, it may face challenges from rising interest rates, which could pressure profitability in certain sectors, and geopolitical risks or regulatory changes in key regions that could impact its top holdings like ASML, Shell, and Nestlé. Diversification across sectors and countries helps mitigate some risks but does not eliminate them entirely.
IQLT Top 10 Holdings
IQLT’s story right now is all about a handful of international heavyweights setting the tone. ASML is the clear engine of growth, with its rising share price giving the fund a strong tech tailwind. Industrial name ABB and miner BHP are also climbing, adding some extra lift from Europe and Australia. On the flip side, steady but lagging defensives like Nestlé and insurers such as Allianz are losing a bit of steam. Overall, the ETF leans toward developed markets outside the U.S., with a noticeable tilt toward European quality leaders in tech, industrials, and health care.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 6.30% | $848.62M | €602.01B | 142.79% | 76 Outperform | |
| Allianz | 2.48% | $334.03M | €145.15B | 13.40% | 67 Neutral | |
| Roche Holding AG | 2.12% | $286.24M | $325.50B | 25.62% | 73 Outperform | |
| ABB Ltd | 2.08% | $279.87M | CHF146.07B | 71.89% | 78 Outperform | |
| Nestlé SA | 1.86% | $250.72M | CHF204.31B | -4.13% | 71 Outperform | |
| AstraZeneca | 1.83% | $246.36M | $282.36B | 22.54% | 80 Outperform | |
| Novartis AG | 1.79% | $241.08M | CHF221.88B | 25.65% | 80 Outperform | |
| Zurich Insurance Group | 1.73% | $232.85M | CHF83.71B | 2.79% | 78 Outperform | |
| BHP Group Ltd | 1.64% | $221.54M | AU$308.91B | 70.74% | 68 Neutral | |
| Tokyo Electron | 1.55% | $209.04M | ¥28.82T | 177.04% | 73 Outperform |
IQLT Technical Analysis
Positive
―
Price Trends
48.86
Positive
48.15
Positive
46.29
Positive
Market Momentum
0.13
Negative
57.23
Neutral
68.65
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IQLT, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 49.10, equal to the 50-day MA of 48.86, and equal to the 200-day MA of 46.29, indicating a bullish trend. The MACD of 0.13 indicates Negative momentum. The RSI at 57.23 is Neutral, neither overbought nor oversold. The STOCH value of 68.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IQLT.
IQLT Peer Comparison
Comparison Results
Performance Comparison
IQLT
iShares MSCI Intl Quality Factor ETF
49.91
7.61
17.99%
VEA
Vanguard FTSE Developed Markets ETF
―
―
―
SCHF
Schwab International Equity ETF
―
―
―
SPDW
SPDR Portfolio Developed World ex-US ETF
―
―
―
IDEV
iShares Core MSCI International Developed Markets ETF
―
―
―
AVDE
Avantis International Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents